Effects of Glucan and Vitamin D Supplementation on Obesity and Lipid Metabolism in Diabetic Retinopathy

. 2018 ; 12 () : 36-45. [epub] 20180330

Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené arabské emiráty Médium electronic-ecollection

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid29760812

BACKGROUND: Diabetes mellitus is a chronic disease manifested by an increase of blood glucose. OBJECTIVE: To evaluate the effects of glucan and vitamin D supplementation in patients with diabetic retinopathy. METHOD: We evaluated the effects of 3-month supplementation with glucan and vitamin D in 54 patients with diabetic retinopathy. We measured levels of vitamin D, cholesterol, HDL cholesterol, and triglycerides. RESULTS: The supplementation strongly decreased the cholesterol levels and improved the levels of HDL cholesterol. In addition, vitamin D levels were strongly improved, but still not at optimal values. CONCLUSION: From our data, we concluded that glucan and vitamin D supplementation strongly influence lipid metabolism and have positive effects on human health.

Zobrazit více v PubMed

Kowluru R.A., Zhong Q., Santos J.M., Thandampallayam M., Putt D., Gierhart D.L. Beneficial effects of the nutritional supplements on the development of diabetic retinopathy. Nutr. Metab. (Lond.) 2014;11(1):8. doi: 10.1186/1743-7075-11-8. PubMed DOI PMC

Fahey J.W., Wade K.L., Wehage S.L., Holtzclaw W.D., Liu H., Talalay P., Fuchs E., Stephenson K.K. Stabilized sulforaphane for clinical use: Phytochemical delivery efficiency. Mol. Nutr. Food Res. 2017;61(4):61. doi: 10.1002/mnfr.201600766. PubMed DOI

Yamagishi S., Matsui T. Protective role of sulphoraphane against vascular complications in diabetes. Pharm. Biol. 2016;54(10):2329–2339. doi: 10.3109/13880209.2016.1138314. PubMed DOI

Zhou Y., Zhang Y., Shi K., Wang C. Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review. Medicine (Baltimore) 2017;96(22):e6754. doi: 10.1097/MD.0000000000006754. PubMed DOI PMC

Atchison E., Barkmeier A. The role of systemic risk factors in diabetic retinopathy. Curr. Ophthalmol. Rep. 2016;4(2):84–89. doi: 10.1007/s40135-016-0098-8. PubMed DOI PMC

Cloetens L., Ulmius M., Johansson-Persson A., Akesson B., Onning G. Role of dietary beta-glucans in the prevention of the metabolic syndrome. Nutr. Rev. 2012;70(8):444–458. doi: 10.1111/j.1753-4887.2012.00494.x. PubMed DOI

Friedman M. Mushroom polysaccharides: Chemistry and antiobesity, antidiabetes, anticancer, and antibiotic aroperties in cells, rodents, and humans. Foods. 2016;5(4):5. doi: 10.3390/foods5040080. PubMed DOI PMC

Maki K.C., Beiseigel J.M., Jonnalagadda S.S., Gugger C.K., Reeves M.S., Farmer M.V., Kaden V.N., Rains T.M. Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods. J. Am. Diet. Assoc. 2010;110(2):205–214. doi: 10.1016/j.jada.2009.10.037. PubMed DOI

Touvier M., Deschasaux M., Montourcy M., Sutton A., Charnaux N., Kesse-Guyot E., Assmann K.E., Fezeu L., Latino-Martel P., Druesne-Pecollo N., Guinot C., Latreille J., Malvy D., Galan P., Hercberg S., Le Clerc S., Souberbielle J.C., Ezzedine K. Determinants of vitamin D status in Caucasian adults: influence of sun exposure, dietary intake, sociodemographic, lifestyle, anthropometric, and genetic factors. J. Invest. Dermatol. 2015;135(2):378–388. doi: 10.1038/jid.2014.400. PubMed DOI

Jesch E.D., Carr T.P. Food ingredients that inhibit cholesterol absorption. Prev. Nutr. Food Sci. 2017;22(2):67–80. PubMed PMC

Novak M., Vetvicka V. Glucans as biological response modifiers. Endocr. Metab. Immune Disord. Drug Targets. 2009;9(1):67–75. doi: 10.2174/187153009787582423. PubMed DOI

Richter J., Svozil V., Král V., Rajnohová Dobiášová L., Stiborová I., Vetvicka V. Clinical trials of yeast-derived β-(1,3) glucan in children: effects on innate immunity. Ann. Transl. Med. 2014;2(2):15. PubMed PMC

Sima P., Vannucci L., Vetvicka V. Glucans and cancer: Historical perspective. Cancer Transl. Med. 2015;1:209–214. doi: 10.4103/2395-3977.172860. DOI

Vetvicka V. Nova Biomedical, New York; 2013. b-Glucans as natural biological response modifiers.

Vetvicka V. Vol. 2. Int Clin Pathol J; 2013. V, J. Why So Many Glucans? .

El Khoury D., Cuda C., Luhovyy B.L., Anderson G.H. Beta glucan: health benefits in obesity and metabolic syndrome. J. Nutr. Metab. 2012;2012:851362. doi: 10.1155/2012/851362. PubMed DOI PMC

Guo L., Tong L.T., Liu L., Zhong K., Qiu J., Zhou S. The cholesterol-lowering effects of oat varieties based on their difference in the composition of proteins and lipids. Lipids Health Dis. 2014;13:182. doi: 10.1186/1476-511X-13-182. PubMed DOI PMC

Queenan K.M., Stewart M.L., Smith K.N., Thomas W., Fulcher R.G., Slavin J.L. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr. J. 2007;6:6. doi: 10.1186/1475-2891-6-6. PubMed DOI PMC

Whitehead A., Beck E.J., Tosh S., Wolever T.M. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2014;100(6):1413–1421. doi: 10.3945/ajcn.114.086108. PubMed DOI PMC

Vetvicka V., Vancikova Z. Anti-stress action of several orally-given β-glucans. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2010;154(3):235–238. doi: 10.5507/bp.2010.035. PubMed DOI

Vetvicka V., Vetvickova J. Anti-stress action of an orally-given combination of resveratrol, β-glucan, and vitamin C. Molecules. 2014;19(9):13724–13734. doi: 10.3390/molecules190913724. PubMed DOI PMC

Krakauer N.Y., Krakauer J.C. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7(7):e39504. doi: 10.1371/journal.pone.0039504. PubMed DOI PMC

Organization W.H. World Health Organization; 2011. Waist Circumference and waist-hip ratio, Report of a WHO expert consultation,Geneva. pp. 8–11.

Wang S., Liu Y., Li F., Jia H., Liu L., Xue F. A novel quantitative body shape score for detecting association between obesity and hypertension in China. BMC Public Health. 2015;15:7. doi: 10.1186/s12889-014-1334-5. PubMed DOI PMC

Pannu P.K., Piers L.S., Soares M.J., Zhao Y., Ansari Z. Vitamin D status is inversely associated with markers of risk for type 2 diabetes: A population based study in Victoria, Australia. PLoS One. 2017;12(6):e0178825. doi: 10.1371/journal.pone.0178825. PubMed DOI PMC

Čapková N. Selected Population Health Indicators in the Czech Republic-EHES 2014. Hygiena. 2017;2017:35–37. doi: 10.21101/hygiena.a1511. DOI

Kubínová R. Public Health Institute Praha; 2016. National Health Observatory in the Czech Republic.

Talbott S.M., Talbott J.A. Baker’s yeast beta-glucan supplement reduces upper respiratory symptoms and improves mood state in stressed women. J. Am. Coll. Nutr. 2012;31(4):295–300. doi: 10.1080/07315724.2012.10720441. PubMed DOI

Brown L., Rosner B., Willett W.W., Sacks F.M. Cholesterol-lowering effects of dietary fiber: A meta-analysis. Am. J. Clin. Nutr. 1999;69(1):30–42. doi: 10.1093/ajcn/69.1.30. PubMed DOI

Ho H.V., Sievenpiper J.L., Zurbau A., Blanco Mejia S., Jovanovski E., Au-Yeung F., Jenkins A.L., Vuksan V. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br. J. Nutr. 2016;116(8):1369–1382. doi: 10.1017/S000711451600341X. PubMed DOI

Vetvicka V., Vetvickova J. Effects of yeast-derived beta-glucans on blood cholesterol and macrophage functionality. J. Immunotoxicol. 2009;6(1):30–35. doi: 10.1080/15476910802604317. PubMed DOI

Jenkins D.J., Kendall C.W., Axelsen M., Augustin L.S., Vuksan V. Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease. Curr. Opin. Lipidol. 2000;11(1):49–56. doi: 10.1097/00041433-200002000-00008. PubMed DOI

Caz V., Gil-Ramírez A., Largo C., Tabernero M., Santamaría M., Martín-Hernández R., Marín F.R., Reglero G., Soler-Rivas C. Modulation of cholesterol-related gene expression by dietary fiber fractions from edible mushrooms. J. Agric. Food Chem. 2015;63(33):7371–7380. doi: 10.1021/acs.jafc.5b02942. PubMed DOI

Lim M.K., Ku S.K., Choi J.S., Kim J.W. Effect of polycan, a β-glucan originating fromAureobasidium,on a high-fat diet-induced hyperlipemic hamster model. Exp. Ther. Med. 2015;9(4):1369–1378. doi: 10.3892/etm.2015.2238. PubMed DOI PMC

Wu Y.S., Ho S.Y., Nan F.H., Chen S.N. Ganoderma lucidum beta 1,3/1,6 glucan as an immunomodulator in inflammation induced by a high-cholesterol diet. BMC Complement. Altern. Med. 2016;16(1):500. doi: 10.1186/s12906-016-1476-3. PubMed DOI PMC

Kusmiati, Dhewantara F.X. Cholesterol-lowering effect of beta glucan extracted from Saccharomyces cerevisiae in rats. Sci. Pharm. 2016;84(1):153–165. doi: 10.3797/scipharm.ISP.2015.07. PubMed DOI PMC

Anderson J.W., Gustafson N.J. Hypocholesterolemic effects of oat and bean products. Am. J. Clin. Nutr. 1988;48(3) Suppl.:749–753. doi: 10.1093/ajcn/48.3.749. PubMed DOI

Anderson J.W., Story L., Sieling B., Chen W.J., Petro M.S., Story J. Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. Am. J. Clin. Nutr. 1984;40(6):1146–1155. doi: 10.1093/ajcn/40.6.1146. PubMed DOI

Braaten J.T., Wood P.J., Scott F.W., Wolynetz M.S., Lowe M.K., Bradley-White P., Collins M.W. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur. J. Clin. Nutr. 1994;48(7):465–474. PubMed

Mehmood Z.H., Papandreou D. An updated mini review of vitamin D and obesity: Adipogenesis and inflammation state. Open Access Maced. J. Med. Sci. 2016;4(3):526–532. doi: 10.3889/oamjms.2016.103. PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...